We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Uruguay, one of Latin America's smaller drug markets, is to unify its government
drug purchasing structures in an effort to boost the state's bargaining power
and drive down costs.
The European Commission has announced that it does not intend to adopt a
specific position on gene sequencing patents, according to international reports.
Epimmune Inc. today announced it had been notified by Syngenta that all conditions
had been met for the assignment of certain portions of Epimmune's existing agreement
with Aeres Biomedical to Syngenta.
Aphios Corporation today announced that it has entered a Research and Development
collaboration with two Japanese companies, Bio Research Corporation of Yokohama,
Yokohama, Japan and Tokyo Supply, Ltd., Minato, Japan to develop an orally-bioavailble
anti-cancer therapaeutic.
Biomira Inc. announced today that it has exercised its put option to acquire
an equity position in Prima BioMed Ltd. ("Prima"), an Australian biotech
company.
Okamoto announced on July 13 that the company has decided to transform Ichijiku
Pharmaceutical into its wholly owned subsidiary through a share exchange as
of October 1.
Fytokem Products Inc. (Fytokem) today announces it has completed an exclusive
marketing agreement with an Indian based pharmaceutical manufacturer, Unimarck
Pharma (India) Ltd. (Unimarck).
Iran's underdeveloped drug sector could benefit from trade liberalisation,
but despite the easing of US opposition to the country's WTO membership, politics
look set to continue to play an integral part in the development of this potentially
huge market.